Accriva Diagnostics invites you to join in us for our upcoming webinar, “Transitioning from Hemochron Response to the Signature Elite – A Case Study”.
In this highly anticipated webinar, guest presenter Mary Jo Grodsky BS, MLS (ASCP), Point of Care Coordinator for Orlando Regional Medical Center, will detail best practices of converting from a tube-based to a cuvette-based ACT point-of-care test system. She will share the various aspects and key learning from Orlando Regional’s own conversion of over 30 Hemochron Response tube-based systems to the Signature Elite cuvette-based system.
Date: Tuesday, February 28, 2017
Time: 7:00 am United States PST
The Accriva organization would like to announce that we have been acquired by Werfen Life Group, S.A., (Werfen), and its subsidiary, Instrumentation Laboratory (IL). Accriva’s globally recognized portfolio of POC diagnostic products for coagulation and anti-platelet therapy response will allow IL to establish a market-leading position in hospital-based POC Hemostasis testing, expand its position in POC Critical Care testing and complement its leadership of the Hemostasis Laboratory market.
We are committed to assuring that all of our customers and partners will experience no disruptions as a result of this change.
View the press release below or view it online.